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European Union Regulation 258/97 defines novel foods as food products and food ingredients that have not been consumed to a significant degree
in the European Union before May 1997. However, there are new foods that for some reason are not considered as novel foods, though we think
that safety of these products is not always a priori established. We defined a ‘grey area’ which consists of such foods, and the present paper intends
to raise awareness of this ‘grey area’ of unidentified novel foods. The grey area of novel foods is divided into two categories: (1) food products or
ingredients for which the current Regulation leaves too much space for different interpretations and (2) food products or ingredients that are not
novel according to the current Regulation, because the current Regulation contains gaps. These categories are illustrated by means of products
already on the market in The Netherlands. We found about two dozen examples of products that had not been identified as novel foods according
the current Regulation, yet could be considered to be classified as novel foods and hence for which a safety evaluation (toxicological and/or
nutritional) would be indicated.
Novel foods: European Union Regulation 258/97: Grey areas: Food safety
Until 1997, consumption of traditional as well as new food pro-
ducts was generally assumed to be safe. Then, the food industry
started to introduce more and more new products into the
consumer market. This, in combination with the increase in
worldwide production and trade flows of foods and the rise
of modern biotechnology, gave rise to the introduction of
European Union (EU) Regulation 258/97, in the present paper
referred to as ‘the Regulation’(1).
The Regulation was established to guarantee that new
foods and food ingredients: (1) would not present a danger
to the consumer, (2) would not mislead the consumer and
(3) would not differ from food products or food ingredients
for which new food products are a substitute to such an
extent that normal consumption of those new products
would be nutritionally disadvantageous for the consumer(2).
According to the Regulation, novel foods are food products
and food ingredients that have not been used for human con-
sumption to a significant degree within the European Commu-
nity before 15 May 1997 and fall in one (or more) of the
categories below (quoted from EU Regulation 258/97(3)):
(i) ‘foods and food ingredients with a new or intentionally
modified primary molecular structure;
(ii) foods and food ingredients consisting of or isolated
from micro-organisms, fungi or algae;
(iii) foods and food ingredients consisting of or isolated
from plants and food ingredients isolated from animals,
except for foods and food ingredients obtained by tra-
ditional propagating or breeding practices and having
a history of safe food use;
(iv) foods and food ingredients to which has been applied a
production process not currently used, where that pro-
cess gives rise to significant changes in the composition
or structure of the foods or food ingredients which affect
their nutritional value, metabolism or level of undesir-
able substances’.
Initially, foods and food ingredients containing or consist-
ing of GM organisms and those produced from, but not
containing, GM organisms were also considered as novel
foods. However, since 18 April 2004 for these foods and
food ingredients a separate Regulation is in force(4).
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Authorisation or notification
Novel foods have to be officially approved through the novel
foods authorisation procedure before introduction on the
European market. An application for authorisation contains a
specification of the novel food, a description of the effects of
the applied production processes, a description of the history
of the organism used as a source, information on the anticipated
intake, information from previous human exposure to the novel
food, nutritional information, biological information, toxico-
logical information, and information on labelling(5).
In every EU country an organisation is authorised to review
national novel foods dossiers, for example, the Ministry of
Health and the Ministry of Agriculture. In the present paper
such organisations are referred to as ‘competent authority’.
The producer must submit an application for authorisation
to both the competent authority in one of the European
member states and to the European Commission. ‘A compe-
tent authority arranges for an assessment of the product for
consumer safety. The safety assessment is performed on the
basis of current scientific knowledge. The competent authority
uses the safety assessment as a basis for reaching a national
decision. All the other EU member states are then invited to
assess the dossier of the applicant and the initial assess-
ment from the competent authority. This assessment by the
other member states is called a ‘second opinion’. If a dossier
raises so many questions that consensus between the member
states is unachievable, the European Commission requests
advice from the European Food Safety Authority (EFSA).
The formal decision-making on authorizing a novel food
takes place in the Standing Committee for the Food Chain
and Animal Health and, if necessary, in the European
Council of Ministers. Once authorised, the product may be
sold across the European Union.’(6). The Regulation is cur-
rently under review(7) and our aim is to raise attention to
some of the challenges.
If new foods or food ingredients are very similar to existing
products, the company may follow a simplified (notification)
procedure. Such a procedure evaluates substantial equivalence
to existing foods or food ingredients (with regards to their
composition, nutritional value, metabolism, intended use and
the level of undesirable substances contained therein)(5).
A ‘history of safe use’ of the comparable product is an important
aspect underlying the principle of substantial equivalence(8).
In practice, it is the producer who decides to characterise a
food as a novel food and decides whether a new product
should go through an authorisation or notification procedure.
In each member state, an enforcement body has the responsi-
bility to monitor these notifications, typically a national food
safety authority.
Rationale
Whereas most foods are clearly traditional foods and some
are clearly novel foods, it is our concern that not all new
foods or food ingredients for which safety of consumption
remains to be established are recognised as novel food. We
refer to such foods, which may pose a potential hazard and
possible risk for public health, as the ‘grey area of
novel foods’. The presence of such foods caused us to raise
a discussion on this topic.
Some discussion papers refer to gaps in the Regulation that
could cause a grey area of concern. With regard to the termi-
nology that is used within the Regulation, i.e. ‘significant
degree’, it can be argued that ‘significant’ is a qualitative
term, the interpretation of which may vary according to the
(subjective) priorities of the applicant(9,10). What is significant
to one interest may be insignificant to another, despite objec-
tive facts. Furthermore, the European Commission has written
a discussion paper(11) concerning comments on the current
Regulation on novel foods. An important comment concerns
the category ‘foods and food ingredients to which has been
applied a production process not currently used, where that
new process gives rise to significant changes in the compo-
sition or structure of the foods or food ingredients which
affect their nutritional value, metabolism or level of undesir-
able substances’(3). The main implementation issue in relation
to this category is confusion about what exactly is meant by a
‘significant change’ in the composition or structure of foods,
given that production processes always involve some change
of this nature.
The present paper provides an overview of the problems
and challenges that cause this grey area and illustrates these
problems by means of several examples found on the Dutch
market. It gives an overview of the grey area of novel foods
on the Dutch market, as well as suggestions on how to cor-
rectly characterise these foods as novel foods.
Therefore, we addressed the following two questions:
(1) To what extent does a grey area exist consisting of foods
that have been introduced onto the market since May
1997 that could be classified as novel, but, however,
have remained unidentified as such?
(2) If such a grey area of novel foods exists, then what are its
possible causes (and potential consequences and risks)?
Methodology
Since to date there was no prior literature on the grey area
of novel foods, we started with defining the grey area, fol-
lowed by identifying food products that would fall within
this definition. We listed unclarities related to the Regu-
lation, which could form the demarcation of the grey area.
Issues related to novel foods were based on the interpret-
ation of the literature, food regulations and the opinion of
experts. The following issues concerning the grey area
were listed:
Additives;
Flavourings;
Supplements;
Fortified foods with vitamins and minerals;
Herbal supplements;
The term ‘significant degree’;
Shift in target group;
Traditional breeding methods;
Growth stage of crops;
Change in production process.
Next, a literature study was conducted to underpin a clear
definition of the grey area of novel foods. Subsequently, we
identified actual products that fall within the definition of
the grey area.
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During the course of our research, the Health Council of the
Netherlands (HC) published a report in which they addressed a
number of the issues we address in the present paper. From
1999 to 2004, the Netherlands Committee on Safety Assess-
ment of novel foods (VNV; Veiligheidsbeoordeling Nieuwe
Voedingsmiddelen) carried out a large number of dossier
assessments of novel foods applications. Based on these
findings, the HC had composed an advisory report on issues
associated with the implementation of the Regulation and
accompanying developments(12). Apart from an overview of
the current implementation of the Novel Food Regulation in
general terms, the HC discusses issues of the Regulation and
includes comments that largely concur with our notion of
weaknesses of the Regulation. The HC did not provide, how-
ever, details on products. The HC report combined with own
research forms the basis for the present paper.
Food products and ingredients excluded from the present
study
To several foods and ingredients a regulation other than the
Novel Foods Regulation applies, and we have excluded these
from the present paper: additives; flavourings; supplements;
foods fortified with vitamins and minerals; GM organisms.
Additives. Additives are defined as ‘any substance not nor-
mally consumed as a food in itself and not normally used as a
characteristic ingredient of food whether or not it has nutritive
value, the intentional addition of which to food for a technologi-
cal purpose in the manufacture, processing, preparation, treat-
ment, packaging, transport or storage of such food result, in it
or its by-products becoming directly or indirectly a component
of such foods.’(13). Examples of additives are preservatives,
sweeteners and thickeners.
Flavourings. Flavourings are substances ‘used or intended
for use in or on foodstuffs to impart odour and/or taste, and to
source materials used for the production of flavourings’(14).
Art 1 (2) of Directive 88/388/EEC defines different types of
flavourings, such as natural or artificial flavouring substances.
Supplements. Supplements are defined as ‘foodstuffs of
which the purpose is to supplement the normal diet and which
are concentrated sources of nutrients or other substances with a
nutritional or physiological effect, alone or in combination, mar-
keted in dose form, namely forms such as capsules, pastilles,
tablets, pills and other similar forms, sachets of powder,
ampoules of liquids, drop dispensing bottles, and other similar
forms of liquids and powders designed to be taken in measured
small unit quantities’(15). Food supplements were excluded from
the present research, as this would open an in-depth investi-
gation into all kinds of food supplements via a large variety
of outlets.
Foods fortified with vitamins and minerals. European
Regulation 1925/2006 concerns food products fortified with
vitamins and minerals. It states that the European Commission
will compose a repertorium of ‘legal’ vitamins and minerals
and the conditions for their use. Vitamins and minerals that
are already being used in a member state during the introduc-
tion of the Regulation are allowed to be used in that member
state for 7 years after entering the market if the member state
provides the European Food Safety Authority with a safety
report(16). In addition to vitamins and minerals, EU Regulation
1925/2006 also deals with ‘other substances’ and provides for
lists of substances ‘permitted’, ‘restricted’ or ‘under scrutiny’.
Genetically modified organisms. EU Regulation EU1892/
2003 covers GM organisms and foods. Therefore GM organ-
isms are also exempted from the present study.
Determinants of the size of the grey area
The Regulation includes two arbitrary characteristics that deter-
mine which new food products fall under this Regulation, which
are directly linked to the size of the grey area of novel foods.
These are the time line of 1997 and the European border.
Time line of 1997. To assess whether a food is novel, it
has to be determined if the food product or ingredient has
been significantly consumed in the EU before 15 May 1997.
Foods that were consumed before this date are considered to
be safe if no dangerous health effects were reported in the
past. For new food products that enter the market after this
arbitrarily chosen date, safety is not automatically assumed.
If the Regulation had been implemented on an earlier or
later date, more or fewer food products would be characterised
as novel, respectively.
Example – probiotics and phytosterols:
Food products were enriched with probiotics before 1997.
Therefore, new applications of probiotics do not need to
follow the novel food procedure. Products with phytosterols
on the other hand were first marketed in 2001 and were there-
fore considered as novel. New applications of phytosterols
need to go through the authorisation or notification procedure.
This would not have been the case if phytosterols had been
introduced before 1997.
European border. Food products and ingredients are novel
when they have not been used for human consumption within
the EU(3). This European border changes regularly. Can food
products that are approved as novel food, or have a safe
history of consumption in, for example, the USA or Australia
be regarded as novel in the EU?
In the consideration of whether or not a food is novel, the EU
border plays an important role. However, the number of EU
members is not constant, since regularly new countries join
the EU. As a result, if a food was already consumed in the new
EU country before 15 May 1997, it can suddenly get a history
of use in an EU country. With expansion of the EU, foods that
were traditionally only consumed in a country that has just
become a member state of the EU can be sold on the European
market without the need for safety assessment of that food.
Example – phytostanols:
Phytostanols were introduced as blood cholesterol-lowering
ingredients in the EU when Finland became a member in
1995. As a result these ingredients were consumed in an EU
member state, whereas if Finland had not entered, they would
have to be authorised as novel foods.
Results and discussion
We identified two categories of food products forming a
potential grey area of novel foods:
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(i) Food products or ingredients for which the current Regu-
lation leaves too much space for different interpretations;
(ii) Food products or ingredients that are not novel accord-
ing to the current Regulation, because the current Regu-
lation contains gaps.
Within these categories, subcategories have been defined.
These categories and subcategories will be explained with
examples. Belowwe discuss about two dozen examples that sup-
port the hypothesis that a grey area of novel foods does exist.
Foods for which the current Novel Foods Regulation leaves
too much space for different interpretations
For some products it is difficult to classify them correctly as
novel food or not, because the current Regulation leaves too
much space for different interpretations on a number of
aspects. These aspects will be discussed below.
The term ‘significant degree’ related to consumption before
15 May 1997. The Regulation states that the Regulation
applies to ‘food products and food ingredients that have
not been used for human consumption to a significant
degree within the community before 15 May 1997’(3). How-
ever, a quantification of the concept of ‘significant degree’
is not provided.
For the following examples, it is clear that these products
have been consumed outside the EU. However, it is difficult
to determine whether these have been consumed to a ‘signifi-
cant degree’ within the EU before May 1997.
Examples where the criterion ‘human consumption to a sig-
nificant degree’ may be an issue:
(1) Human consumption of camel milk is common in many
Asian and African countries. It serves as a staple food
of desert nomad tribes. Camel milk differs in composition
from cows’ milk(17).
(2) Teff is an important food grain in Ethiopia and Eritrea
and less so in India and Australia. Traditionally, the
grain is consumed in the form of bread-like pancakes.
In Ethiopia, it accounts for about a quarter of the
total cereal(18).
(3) The pitaya is the fruit of several cactus species, especially
of the genus Hylocereus. Originally the fruit comes from
Central and South America; however, the cacti are also
cultivated in Southeast Asian countries and are also
found in Taiwan, Okinawa, Israel and southern China.
The species Stenocereus gummosus has been an important
food source for native Americans.
(4) The Acai berry originates from the acai palm, which is
found in the Amazon region of Brazil. The juice and
pulp of the acai berry are frequently used in fruit drinks.
(5) Argan oil originates from the Moroccan tree Argania
spinosa. Besides cosmetic application in skincare
products, Argan oil is used for cooking. In 2002, Argan oil
became a fashionable food in Europe and North America.
(6) Vemma drink is a fruit juice available at Dutch health
shops which contains mangosteen, a fruit from South
East Asian tropical trees.
The term ‘significant changes’ related to change in pro-
duction process. One of the categories of foods that the
Regulation applies to is: ‘foods and food ingredients to
which has been applied a production process not currently
used, where that process gives rise to significant changes
in the composition or structure of the foods or food ingredi-
ents which affect their nutritional value, metabolism or level
of undesirable substances’(3). This definition is not always
clear, since one could debate about the term ‘significant
changes’. This term is not quantified, which results in
leaving room for different interpretations. Moreover, a pro-
blem with the change of production processes is that until
it is investigated thoroughly (which is necessary for the
authorisation procedure), it is unknown how much the com-
position differs from that of the original counterpart. How-
ever, this type of information is already needed before the
authorisation procedure, at the state of consideration if a
food product or ingredient is novel or not. In the current
situation this information is only necessary in the authoris-
ation procedure.
A discussion paper of the European Commission (2002)
about the Regulation already mentions the issue of significant
changes related to change in production process. It did not pro-
vide, however, concrete examples of products in this category.
Examples where the criterion ‘significant changes related to
change in production process’ may be an issue:
(1) In 2003, Mycryo was introduced as a powdered form of
cocoa butter. Mycryo is produced by a cryogenisation pro-
cess, in which liquid cocoa butter is cooled at an extremely
low temperature to form it into a powder. In the chocolate
industry, Mycryo is used to facilitate the crystallisation
of chocolate and is also used in savoury preparations as a
replacement for the usual cooking fats and in pastry as an
alternative to gelatine. Though cocoa butter has already
been used for a long time, its use in cryogenisated form
with its specific characteristics is new.
(2) Tivall is a plant-based alternative to meat invented in
Israel, and derived from wheat gluten and vegetable pro-
teins. It is claimed that a unique and patented technology
is used to transform selected ingredients into Tivall
products. The production of Tivall is a ‘secret’ process,
although it is known that wheat proteins and vegetable
proteins are blended to form a base matrix. This meat-
like matrix is fortified with vitamins and minerals and
blended with a combination of vegetable oil, flavourings,
spices, water and egg protein.
(3) Quart mostly consists of mushrooms, but, however, also
of 25% meat. Quart food products are hamburgers,
schnitzels and filets. Quart products are made by combin-
ing meat-based processes with vegetable-based processes,
which causes Quart products’ nutritional value and
metabolism to differ from real meat products. These pro-
cesses themselves are not new. However, combining
meat- and vegetable-based processes results in a new
production process.
(4) Valess products are meat substitutes based on a dairy con-
centrate of fresh milk and a vegetable substance to which
ingredients have been added that create structure and
taste. The production process of Valess is initially a dairy
process, which is followed by a meat-based process.
(5) PeptoPro is a sport drink that contains hydrolysed pro-
teins. The use of proteins in ready-to-use sports drinks
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was limited up to now as there were dissolution problems,
as well as stability and digestive problems when complete
proteins were used. Normal sports drinks contain water
for rehydration, glucose and/or electrolytes. PeptoPro
now adds hydrolysed protein in dissolvable form.
(6) Vitaalbrood Pro´-FIT contains a high level of b-glucan,
a soluble fibre. The b-glucan comes from OatWell oat
bran, which due to a special stabilisation process contains
very high levels of b-glucan. The level of b-glucan in
OatWell oat bran is about ten times as high as in a ser-
ving of rolled oats, oatmeal or oat flakes of the same size.
Animal feed related to changed composition of foods.
Changes in the composition of an animal product due to a
change in the composition of the animal feed are part of the
problem category of interpretation of the Regulation. The
HC already mentions this issue. The Netherlands Safety
Assessments on Novel Foods Committee regards these pro-
ducts as novel, depending on the change of concentration
and nature of components(12). For the two following examples,
it is questionable whether the changed composition is import-
ant enough to position the product within the grey area.
Examples – amended animal products:
(1) The Columbus egg has a fatty acid composition that dif-
fers from eggs traditionally consumed because the feed
for the chicken has a different composition from the
feed that is traditionally given to chickens in the egg
industry. The eggs are higher in n-3 fatty acids and
lower in SFA.
(2) In May 2005, Aurora cheese was introduced onto the
Dutch market, which contains higher levels of conjugated
linoleic acid and n-3 fatty acids than normal cheese. The
basis for this cheese is milk produced by cows that are
given special feed. This milk contains at least 10mg con-
jugated linoleic acid per g fat and the proportion of n-3 to
n-6 fatty acids is at least 1 to 3(19).
New varieties of organisms. For products that consist of or
are isolated from new plants or animals that are the result of
traditional propagating and breeding methods, the criterion
of whether or not to consider a product as a novel food is
not clear. When using the species line as a criterion to call a
product novel or not, foods from plant varieties are not
regarded as novel. However, new varieties may have a differ-
ent structure or composition and may therefore differ in their
nutritional value, their level of undesirable substances, or in
the way they are metabolised. Therefore, it has already been
pointed out that in some cases the variety line is a more appro-
priate criterion for characterising a food as novel or not(12).
For the following examples, it is not clear whether they
should be treated as novel according to the current Regulation.
Examples – new varieties of organisms:
(1) Many different potato varieties exist and the composition
of these varieties differs. For example, substances in pota-
toes that differ widely for different potato varieties are
glycoalkaloids(20). Since these substances are potentially
toxic for humans, it is desirable that glycoalkaloid
levels are be evaluated before new potato varieties are
released for consumption.
(2) Bimi is a relatively new vegetable that looks like broc-
coli, but has a longer and more slender stem. There is a
year-round supply of bimi, mostly from Africa. The veg-
etable was developed using normal horticultural breeding
techniques, without genetic modification: bimi is a cross
between broccoli and china kale and contains high
levels of glucosinolates.
(3) The Santessa tomato is developed by a process of normal
horticultural breeding techniques. This new tomato variety
contains a higher level of lycopene than the traditional
tomato.
(4) From May 2007 onwards, besides white and green, also
purple asparagus is available in the Netherlands. Purple
asparagus (Aspara pacific) originated as a spontaneous
mutation in northern Italy 300 years ago and with breed-
ing programmes this purple asparagus is made commer-
cially interesting now for farmers. Its purple colour
comes from anthocyanins.
(5) The golden kiwi originates from New Zealand and was
introduced to Europe in 2000. The golden kiwi is a
new cultivar group from the green kiwi and resembles
the green kiwi in growth patterns and outward appear-
ance. The golden kiwi is also used for juices.
(6) Probiotics are ‘living micro organisms, which upon inges-
tion in sufficient numbers exert health benefits’. In the
1980 s, the Nordic countries received the first-generation
probiotics, often including Lactobacillus acidophilus as
the effective probiotic in fermented milks. In 1990, Lacto-
baccillus rhamnosus was introduced to Finland, and
shortly thereafter in Italy and the Netherlands. In 1994,
Lactobacillus casei, Shirota strain, was introduced to the
Netherlands by Yakult. Since 1994, many more products
containing probiotic bacteria have entered the market.
Today, a multitude of so-called probiotics are available
throughout the EU, but actually not all of them fulfil the
criteria set by the WHO expert group(21) requiring that
for each probiotic both health benefits and safety should
be scientifically substantiated. Although new probiotic
products often contain bacteria from the same genus or
even the same species, different varieties (strains) are used.
Foods for which the current Novel Foods Regulation contains
gaps
This category deals with food products or ingredients that are
not novel according to the current Regulation, even though the
safety of consumption is not a priori established.
Safety not assessed for new target groups. New food pro-
ducts containing ingredients that have been used before 1997
and for which no harmful effects have been demonstrated
are not novel foods. However, sometimes, existing products
are aimed at a new target group, such as young children,
pregnant women or the elderly. When in these target groups
the physiological effects of these foods are unknown, the
foods belong to the grey area. In this case, not the composition
of the product determines the novel status, but the new mar-
keting concept.
Examples where the criterion ‘target group of the product’
may be an issue:
(1) Fristi Xtra is a probiotic drink that aims at a new, specific
target group: children from the age of 1 year onwards.
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Probiotic foods have been consumed to a significant degree
before May 1997 and are therefore not characterised as
novel. Though consumption of probiotics is generally
considered to be safe for adults, the effects in children
might be different. Adverse effects due to immunomodula-
tion in young children cannot be ruled out yet(22).
(2) Different foods for infants and young children sup-
plemented with probiotics and prebiotics are currently
marketed in the Netherlands and most other European
Community countries. Breast milk bifidobacteria and
lactic acid bacteria are considered to be beneficial for
health, but there is not much scientific information avail-
able on possible adverse effects of supplementary appli-
cation in young children(22). Prebiotics may function
differently as they do not resemble breast milk oligosac-
charides. Infants may form a group at risk for the adverse
effects of probiotic and prebiotics due to, for example,
immunomodulation, which may differ from the effects
for adults.
Growth stage of crops. Except from synthetically pro-
duced food ingredients, most foods contain vegetable-based
substances. These organisms may have a different compo-
sition during different growth stages of the crops. Since con-
suming crops while they are in a different growth stage than
when they are normally consumed has unknown health effects,
such products belong to the grey area, as is the case for the
following examples.
Examples – new varieties of growth stages of crops:
(1) Verjuice is an acidic juice, originally from France, made
by pressing unripe grapes and it is used in salads as a sour
substitute for vinegar and lemon.
(2) White tea comes from the Camellia sinensis plant. The
leaves are picked and harvested before they open fully,
when the buds are still covered by fine white hair.
(3) Broccocress is broccoli in a younger stage, more specifi-
cally, the sprout stage. Broccocress is a new product
within the group of germ vegetables. Though the sprouts
and mature broccoli originate from the same organism,
the nutritional value differs. Sprouts, 3 d old, of certain cru-
cifers including broccoli and cauliflower contain 10–100
times higher levels of glucoraphanin (the glucosinolate of
sulforaphane) than do the corresponding mature plants(23).
Single product intake v. total ingredient intake. The Regu-
lation covers the application of a new product or ingredient
and not of the total consumption of a specific ingredient. In
addition, the total level of consumption of an ingredient is
usually not taken into account in the case of a new application
of a food that was already on the market. It is obvious that sig-
nificantly altered intake may pose risks. Some examples are
discussed below.
Examples – single product intake v. total ingredient intake:
(1) Consumption of n-3 fatty acids may reduce the risk of
CHD. Nowadays, many food products are enriched with
n-3 fatty acids. However, with overuse of these fatty
acids, negative health effects have been suggested(24).
The combination of the consumer’s increased awareness
of nutrition and health, and more products being enriched
with n-3 fatty acids may result in a high total intake of
n-3 fatty acids.
(2) With an increasing number of probiotic food products
and supplements entering the market, levels of intake
of different probiotic bacteria may go up. As indicated
earlier, adverse health effects of probiotics are unknown,
and this is even more true of the health effects of high levels
of intake and/or combination of different probiotic strains.
Conclusion
The present paper aims to give a clear overview of the pro-
blems that give rise to the existence of the grey area and to
illustrate these problems and challenges by means of several
actual and clear examples. Currently, the EU and the HC
point out that implementation of the current Regulation some-
times gives problems and may not always identify all new
food products that can possibly harm consumer health. Even
though virtually all parties admit that the current Regulation
has weaknesses, until now, there has been hardly any systema-
tic approach to solve these issues.
We have provided an overview of some of the challenges
around the Regulation. It defines a grey area of novel foods
and lists food products that are on the market in the Nether-
lands and some other countries in the EU in the autumn of
2007 for which the safety of consumption was not a priori
established and which did not go through the authorisation
or notification procedure for novel foods. Table 1 represents
a reasoning for the existence of the grey area of novel
foods, including the two categories demarcating the grey
area in the present report, and provides an overview of poten-
tially novel food examples. From Table 1, one can conclude
that most of the potential novel foods discussed in the present
paper owe their potential novel status to the Regulation, i.e.
leaving too much room for different interpretation on a
number of aspects, such as the quantification of the ‘signifi-
cant degree’ of consumption of food products before 1997
and the quantification of ‘significant changes’ in the compo-
sition or structure of food products caused by new production
processes. It is important that these aspects are identified and
more closely defined when the Regulation is revised in the
near future(7).
In conclusion, the Dutch and European food markets con-
tain food products that could actually be classified as novel
foods, but remain unidentified as such. It is shown that such
products do exist. If the existence of this grey area is acknowl-
edged, the current list of EU novel foods would be much
larger(25,26). It is difficult to speculate on the size of the grey
area of novel foods, especially since such a conclusion
would rely on the definition of what would or would not fall
into that area. For the purpose of the present paper, we have
identified about two dozen types of grey area novel foods.
It should be emphasised that even though the present study
indicates that the current Regulation may not identify all new
foods, food ingredients or applications that enter the market,
the conclusion from this should not be that the products men-
tioned in the present report are unsafe, but merely that for
these products the safety (toxicological and/or nutritional)
of consumption cannot automatically be assumed. In con-
clusion, the present overview indicates that the Novel
Foods Regulation, currently being revised, should take this
‘grey area’ of novel foods into consideration. In any case
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in addition to the suggestions of the European Commission(7),
follow-up studies, such as Post-Launch Monitoring(8) could
be put in place in order to shed light on the intake and mag-
nitude, if present, of potentially adverse health effects of
these products.
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